What Is Exosome Therapy?
Exosomes are nanoscale vesicles that cells throughout the body produce and release as a fundamental part of their communication infrastructure. They do not act directly on tissue; instead, they function as biological messengers, carrying proteins, lipids, and genetic material, including RNA, between cells, transmitting the instructions that regulate tissue repair, modulate immune activity, and control inflammation. In clinical use, exosomes are derived from donor mesenchymal stem cells and produced under carefully controlled laboratory conditions. No living cells are introduced into the body. What is delivered instead is the molecular payload those cells would naturally produce—growth factors, cytokines, and regulatory RNA—giving the patient's own cells the biological direction they need to initiate and sustain a repair response.
How Exosomes Compare to PRP and Bone Marrow Aspirate
PRP and bone marrow aspirate concentrate healing agents are drawn directly from the patient's own blood or marrow. Exosomes work through a fundamentally different mechanism. They are manufactured externally, contain no living cells, and target cellular behavior at a molecular level rather than increasing the local concentration of growth factors. That acellular nature reduces certain risks associated with cell-based therapies and allows exosomes to be produced with a degree of biological consistency that autologous treatments cannot replicate. For patients whose condition has not responded adequately to PRP or conventional injections, exosomes offer a more precise and targeted mechanism of action, one that engages the repair process at a deeper cellular level.
Where Exosome Therapy Fits in Our Regenerative Program
Exosome therapy at our West Orange location is one component of a broader regenerative program that also includes platelet-rich plasma, bone marrow aspirate, and disk cell and scaffold treatment. Whether exosomes are used on their own or in combination with other biologics depends entirely on the individual patient's condition, the specific structures involved, and the degree of degeneration present. That determination is made through careful clinical evaluation, not a standardized treatment menu.